Immix Biopharma, Inc. is a biopharmaceutical company focused on developing tissue-specific therapeutics for cancer and immune-related diseases. They are currently working on clinical trials for soft tissue sarcoma, colorectal cancer, and multiple myeloma in collaboration with BeiGene Ltd.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing